Deep Phenotyping of Rosacea and Migraine
NCT03872050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 613
Last updated 2020-08-12
Summary
This study aims to deep phenotype patients with rosacea and migraine
Conditions
- Migraine
- Rosacea
Interventions
- DIAGNOSTIC_TEST
-
No intervention apart from tests, including interview
No interventions
Sponsors & Collaborators
-
Danish Headache Center
lead OTHER
Principal Investigators
-
Messoud Ashina, MD, PhD, DMSc · Professor
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-14
- Primary Completion
- 2019-10-29
- Completion
- 2019-10-29
Countries
- Denmark
Study Locations
More Related Trials
-
A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention
NCT01617941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Suppressive Functions of Regulatory T Cells in Migraine
NCT07067112 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis
NCT02639598 ·Status: COMPLETED ·Phase: PHASE4
-
DFN-02 Open Label Safety Study in Patients With Acute Migraine
NCT02279082 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
NCT00095004 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Glymphatic System in Migraine
NCT05907655 ·Status: RECRUITING
-
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)
NCT01613248 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Functional Brain Features in Women with Migraine
NCT06470958 ·Status: RECRUITING
-
Efficacy, Tolerability, and Safety Study of DFN-15
NCT03006276 ·Status: COMPLETED ·Phase: PHASE3
-
Chordate System S020 Acute Migraine Clinical Investigation
NCT02185703 ·Status: TERMINATED ·Phase: NA
-
Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
NCT05211050 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea
NCT03878784 ·Status: COMPLETED ·Phase: NA
-
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947 ·Status: COMPLETED ·Phase: NA
-
Migraine and Body Composition
NCT01720862 ·Status: COMPLETED
-
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725 ·Status: COMPLETED ·Phase: NA
-
A Research Study To Compare Two Kinds Of Daily Headache
NCT00335803 ·Status: COMPLETED
-
Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
NCT02472418 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Real World Study of Rimegepant in the Treatment of Migraine
NCT05709106 ·Status: COMPLETED
-
DFN-11 Injection in Episodic Migraine With or Without Aura
NCT02569853 ·Status: COMPLETED ·Phase: PHASE3
-
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
NCT05854992 ·Status: COMPLETED
-
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
NCT02856802 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding the Pathophysiology of Migraine Pain
NCT03026101 ·Status: TERMINATED ·Phase: NA
-
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
NCT00092963 ·Status: COMPLETED ·Phase: PHASE3
-
Rizatriptan 10 MG RPD in the Treatment of Acute Migraine
NCT01057160 ·Status: COMPLETED ·Phase: PHASE4